These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32339244)

  • 21. Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.
    Schiavotto C; Ruggeri M; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):35-40. PubMed ID: 8039756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease.
    Cheon EJ; Oh JS
    BMC Pediatr; 2024 Jan; 24(1):69. PubMed ID: 38245705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute cerebellar infarction associated with intravenous gammaglobulin treatment in idiopathic thrombocytopenic purpura.
    Choi WJ; Kim MJ; Kim C; Sohn JH; Choi HC
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e9-11. PubMed ID: 22749629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous anti-D immune globulin-induced intravascular hemolysis in Epstein-Barr virus-related thrombocytopenia.
    Levendoglu-Tugal O; Jayabose S
    J Pediatr Hematol Oncol; 2001 Oct; 23(7):460-3. PubMed ID: 11878583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
    Mohamed M; Bates G; Eastley B
    Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
    [No Abstract]   [Full Text] [Related]  

  • 27. Randomized study of IVIg and high-dose dexamethasone therapy for children with chronic idiopathic thrombocytopenic purpura.
    Hedlund-Treutiger I; Henter JI; Elinder G
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):139-44. PubMed ID: 12571466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive effect of intravenous immunoglobulin on peripheral blood neutrophil count in patients with idiopathic thrombocytopenic purpura.
    Sugita K; Eguchi M
    J Pediatr Hematol Oncol; 2005 Jan; 27(1):7-10. PubMed ID: 15654271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of Privigen, a novel liquid intravenous immunoglobulin formulation, in adolescent and adult patients with chronic immune thrombocytopenic purpura.
    Robak T; Salama A; Kovaleva L; Vyhovska Y; Davies SV; Mazzucconi MG; Zenker O; Kiessling P;
    Hematology; 2009 Aug; 14(4):227-36. PubMed ID: 19635187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose intravenous immunoglobulin is strongly associated with hemolytic anemia in patients with Kawasaki disease.
    Nolan BE; Wang Y; Pary PP; Luban NLC; Wong ECC; Ronis T
    Transfusion; 2018 Nov; 58(11):2564-2571. PubMed ID: 30265742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of a new intravenous immunoglobulin (Panzyga
    Arbach O; Taumberger AB; Wietek S; Cervinek L; Salama A
    Transfus Med; 2019 Feb; 29(1):48-54. PubMed ID: 30687970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patients.
    Kahwaji J; Barker E; Pepkowitz S; Klapper E; Villicana R; Peng A; Chang R; Jordan SC; Vo AA
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1993-7. PubMed ID: 19833910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Case of twin pregnancy complicated by idiopathic thrombocytopenic purpura treated with intravenous immunoglobulin: Review of the literature.
    Zhao WX; Yang XF; Lin JH
    Niger J Clin Pract; 2017 Jan; 20(1):115-118. PubMed ID: 27958258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpura.
    Ruggeri M; Castaman G; De Nardi G; Rodeghiero F
    Haematologica; 1993; 78(5):338-9. PubMed ID: 8314166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of intravenous immunoglobulin (Flebogamma
    Apte S; Navarro-Puerto J; Damodar S; Ramanan V; John J; Kato G; Ross C; Shah C; Torres M; Fu C'; Rucker K; Pinciaro P; Barrera G; Aragonés ME; Ayguasanosa J
    Immunotherapy; 2019 Feb; 11(2):81-89. PubMed ID: 30499734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutropenia as a complication of intravenous immunoglobulin (IVIG) therapy in children with immune thrombocytopenic purpura: common and non-alarming.
    Berkovitch M; Dolinski G; Tauber T; Aladjem M; Kaplinsky C
    Int J Immunopharmacol; 1999 Jun; 21(6):411-5. PubMed ID: 10405875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review.
    Crouch ED; Watson LE
    Angiology; 2002; 53(1):113-7. PubMed ID: 11863304
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid irreversible encephalopathy associated with anti-D immune globulin treatment for idiopathic thrombocytopenic purpura.
    Christopher K; Horkan C; Barb IT; Arbelaez C; Hodgdon TA; Yodice PC
    Am J Hematol; 2004 Nov; 77(3):299-302. PubMed ID: 15495245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative treatment-related adverse event cost burden in immune thrombocytopenic purpura.
    Donga PZ; Bilir SP; Little G; Babinchak T; Munakata J
    J Med Econ; 2017 Nov; 20(11):1200-1206. PubMed ID: 28882075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of immunoglobulin G (IgG) interchain disulfide bond cleavage on efficacy of intravenous immunoglobulin for immune thrombocytopenic purpura (ITP).
    Machino Y; Ohta H; Suzuki E; Higurashi S; Tezuka T; Nagashima H; Kohroki J; Masuho Y
    Clin Exp Immunol; 2010 Dec; 162(3):415-24. PubMed ID: 21029072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.